Trial intelligence / Profile preview

BLI800 bowel cleansing in pediatric colonoscopy

2019-003749-14Phase 2

Sponsor
Braintree Laboratories
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of sodium sulfate + potassium sulfate + magnesium sulfate in None (2 arms), sponsored by Braintree Laboratories. Primary endpoint: Percent of subjects with treatment emergent adverse events.

02

Drugs

sodium sulfate + potassium sulfate + magnesium sulfate

Beyond the preview

Go deeper on 2019-003749-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-003749-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call